SCHEMBL1645936

SCHEMBL1645936

CCOC(=O)CC(C)c1ccccc1N

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.49
HSD17B10 Q99714 3/20 0.49
NLRP3 Q96P20 3/20 0.45
TSHR P16473 2/20 0.44
KDM4E B2RXH2 2/20 0.43
HTT P42858 1/20 0.43
CHEK1 O14757 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPC1 O15118 2/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
F2 P00734 1/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1646939 1.00 ALDH1A1 (0.49) ALDH1A1HSD17B10NLRP3TSHRKDM4E
SCHEMBL27618920 0.87 ALDH1A1 (0.55) ALDH1A1HSD17B10TSHRKDM4EMEN1
SCHEMBL28866732 0.83 TSHR (0.58) ALDH1A1NLRP3TSHRMEN1KMT2A
SCHEMBL27810153 0.82 ALDH1A1 (0.46) ALDH1A1HSD17B10NLRP3TSHRKDM4E
SCHEMBL8435913 0.81 NLRP3 (0.45) ALDH1A1NLRP3TSHRHTTMEN1
SCHEMBL13572960 0.81 CASP1 (0.54) ALDH1A1NLRP3TSHRHTTMEN1
SCHEMBL15968923 0.81 POLB (0.48) ALDH1A1NLRP3TSHRHTTMEN1
SCHEMBL27536950 0.81 CA12 (0.45) ALDH1A1HSD17B10NLRP3TSHRKDM4E
SCHEMBL28362327 0.80 TSHR (0.59) ALDH1A1HSD17B10NLRP3TSHRKDM4E
SCHEMBL1646855 0.78 FFAR1 (0.47) ALDH1A1TSHRKDM4EHTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308829-B1 A PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES JIANGSU HENGRUI MEDICINE CO (CN) 2017-06-14 EP disclosed
US-8580997-B2 Process for preparing R-beta-amino phenylbutyric acid derivatives JIANGSU HENGRUI MEDICINE CO. LTD. (CN) 2013-11-12 US disclosed
US-20110130587-A1 PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2011-06-02 US disclosed
EP-2308829-A1 A PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES Jiangsu Hengrui Medicine Co., Ltd. (CN) 2011-04-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130587-A1 PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES ALAD, DAO, DDO ALDH1A1 1465/4885HSD17B10 800/4885NLRP3 1368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.